Influence of DL α-lipoic acid and vitamin-E against doxorubicin-induced biochemical and histological changes in the cardiac tissue of rats

Indian Journal of Pharmacology

Volumn 37, Issue 5, 2005, Pages 294-299

  Ayaz, S A ^a   Bhandari, U ^a   Pillai, K K ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Antioxidants; Cardiotoxicity; Doxorubicin; Free radicals

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; DOXORUBICIN; ENZYME; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL DAMAGE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART; HEART MUSCLE; HEART PROTECTION; HISTOPATHOLOGY; INJECTION; MALE; MONITORING; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN;

EID: 26444569160     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.16852     Document Type: Article

References (35)

1. Lefrak EA, Pitha J, Rosenheim S, Gottlieb T. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973;32:302-14.
2. Yin X, Wu H, Chen Y, Kang YJ. Induction of antioxidants by adriamycin in mouse heart. Biochem Pharmacol 1998;56:87-93.
3. Hershko C, Link G, Tzahor M, Pinson A. The role of iron and iron chelators in anthracycline cardiotoxicity. Leuk Lymphoma 1993;11:207-14.
4. Thomas CE, Aust SD. The release of iron from ferritin by cardiotoxic anthracycline antibiotic. Arch Biochem Biophys 1986;248:684-9.
5. Sinha BK, Politi PM. Antharcyclines. Cancer Chemother Biol Response Modif 1990;11:45-57.
6. Daoud SS. Cell membranes as targets for anticancer drug action. Anticancer Drugs 1992;3:443-53.
7. Kagan VE, Shvedova A, Serbinova E, Khan S, Swanson C, Powell R, et al. Dihydrolipoic acid a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 1992;44:1637-49.
8. Thurich T, Bereiter-Hahn J, Schneider M, Zimmer G. Cardioprotective effects of dihydrolipoic acid and tocopherol in right heart hypertrophy during oxidative stress. Arzneimittelforschung 1998;48:13-21.
9. Balachandar AV, Malarkodi KP, Varalakshmi P. Protective role of DLα-lipoic acid against-induced cardiac lipid peroxidation. Hum Exp Toxicol 2003;22:249-54.
10. Scott BC, Aruoma OI, Evans PJ, O'Neill C, Vander Vliet A, Cross CE, et al. Lipoic acid and dihydrolipoic acid as antioxidants a critical evaluation. Free Radic Res 1994;20:119-33.
11. Hadi M, Lester P, Nils-Erik LS. Antioxidant and prooxidant activities of α-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 2002;182:84-90.
12. Sethi R, Takeda N, Nagano M, Dhalla N S. Beneficial effects of vitamin E treatment in acute myocardial infarction. J Cardiovasc Pharmacol Ther 2000;5:51-8.
13. Tappel AI. Measurement of and protection from in vivo lipid peroxidation. In: Prye WA, editor. Free radicals in Biology. New York: Academic Press; 1980. p. 1-47.
14. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82:70-7.
15. Ohkawa H, Ohish N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid. Anal Biochem 1979; 95:351-8.
16. Lum G, Gambino SR. A comparison of serum versus heparinised plasma for routine chemistry tests. Am J Clin Pathol 1974; 61:108-13.
17. Clairborne A. Catalase activity. In: Greenwald RA, editor. Handbook of methods for oxygen radical research. Boca Raton: CRC Press; 1985. p. 283-4.
18. Marklund SL. Pyrogallol autooxidation. In: Greenwald RA, editor. Handbook of methods for oxygen radical research. Boca Raton: CRC Press; 1985. p. 243-7.
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
20. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 1975;250:5475-80.
21. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974; 249:7130-9.
22. Zaheer N, Tewari KK, Krishnan PS. Exposure and solubilisation of hepatic mitochondrial shunt dehydrogenases. Arch Biochem Biophys 1965;109:646-8.
23. Lowry OH, Rosenbrough NT, Farr AL, Randall AT. Protein measurement with the folins phenol reagent. J Biol Chem 1951;193:265-75.
24. Smith A, Burton J. A color atlas of histological staining techniques. In: Smith A, Burton J, editors. London: Wolfe Medical Publications; 1977.
25. Myers C, Bonow R, Palmeri S, Jenkins J, Corden B, Locker G, et al. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetlycysteine. Semin Oncol 1993;10: 53-5.
26. Herman EH, Ferrans VJ. Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swine. Lab Invest 1983; 49: 69-77.
27. Pritsos CA, Sokoloff M, Gustafson DL. PZ-51 (Ebselen) in vivo protection against adriamycin induced mouse cardiac and hepatic lipid peroxidation and toxicity. Biochem Pharmacol 1992;44:839-41.
28. Doroshow JH, Looker GY, Ifrim I, Myers CE. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest 1981;68:1053-64.
29. Geetha A, Sankar R, Thankmani M, Shyamala Devi CS. α-Tocopherol reduces doxorubicin-induced toxicity in rats histological and biochemical evidence. Indian J Physiol Pharmacol 1990; 34:94-8.
30. Mohamed HE, El-Swefy SE, Hagar HH. The protective effect of glutathione administration on adriamycin induced acute cardiac toxicity in rats. Pharmacol Res 2000; 42:115-21.
31. Abdul Hakeem AAM, Gado A M, AL-Shabanah OA, Mansour M A. Alpha lipoic acid ameliorates myocardial toxicity induced by doxorubicin. Pharmacol Res 2000;46:499-503.
32. Monnet E, Orton C. A canine model of heart failure by intracoronary adriamycin injection: hemodynamic and energetic results. J Cardiac Fail 1999;5:255-64.
33. Deepa P R, Varalakshmi P. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem Biol Interact 2003;146:201-10.
34. Milei J, Boveris A, Llesuy S, Molina HA, Storino R, Ortega D, et al. Amelioration of adriamycin induced cardiotoxicity in rabbits by prenylamine and vitamin A and E. Am Heart J 1986;111:95-102.
35. Van Vleet JF, Greenwood L, Ferrans VJ, Rebar AH. Effect of selenium and vitamin E on adriamycin-induced cardiomyopathy in rabbits. Am J Vet Res 1978;39:997-1010.